Research of PSMA PET for HCC is still in its infancy, and this present meta-analysis established that PSMA PET has an adequate sensitivity to be investigated as a possible candidate for a more reliable PET radiotracer for HCC. This evidence concerns the gene FOLH1 and hepatocellular carcinoma.